Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02526563 · ClinicalTrials.gov registry record
Serum Ropivacaine Concentrations in Pediatric Patients Receiving Continuous Wound Catheter Analgesia
A clinical trial of Alveolar Bone Grafting and Alveolar Cleft Grafting, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 4
- Enrollment target
- 1
- Study location
NCT02526563 is a study of Alveolar Bone Grafting and Alveolar Cleft Grafting that has completed, run by University of Pittsburgh. The registered enrollment target is 4 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02526563, a study of Alveolar Bone Grafting and Alveolar Cleft Grafting, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary investigators in this study plan to investigate serum concentrations of ropivacaine in pediatric patients who already receive as standard of care a continuous wound catheter after an iliac crest alveolar bone graft harvest for completion of a previous cleft palate repair. The goals of this study are 1) to determine serum concentrations (free, unbound) of ropivacaine 2) To evaluate pain scores during the perioperative period to determine efficacy of wound catheters for postoperative analgesia for iliac crest bone graft harvest.
Conditions Studied
Interventions
- PROCEDURE ropivicaine
Study Locations (1)
Pennsylvania
- The Children's Hospital of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2015-08 |
| Est. Completion | 2018-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02526563
The ClinicalTrials.gov registry entry for NCT02526563 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Alveolar Bone Grafting appearing as the primary indexed condition, and to 1 intervention - of which ropivicaine is the first listed.
NCT02526563 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02526563 about?
NCT02526563 is a clinical study titled "Serum Ropivacaine Concentrations in Pediatric Patients Receiving Continuous Wound Catheter Analgesia". The primary investigators in this study plan to investigate serum concentrations of ropivacaine in pediatric patients who already receive as standard of care a continuous wound catheter after an iliac crest alveolar bone graft harvest for completion of a previous cleft palate repair. The goals of t...
What is the current status of trial NCT02526563?
This trial is currently completed. The enrollment target is 4 participants. The study started on 2015-08. Estimated completion is 2018-08.
What conditions does trial NCT02526563 study?
This clinical trial studies the following conditions: Alveolar Bone Grafting, Alveolar Cleft Grafting.
What interventions are being tested in trial NCT02526563?
The interventions under investigation include: ropivicaine (PROCEDURE).
Who is sponsoring clinical trial NCT02526563?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02526563 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alveolar Bone Grafting
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.